化学療法誘導の吐き気と嘔吐(CINV)の予防における最近の発展: 包括的レビュー

JORDAN K.; JAHN F.; AAPRO M.

文献

J-GLOBAL ID：201502200630779714 整理番号：15A0776229

化学療法誘導の吐き気と嘔吐(CINV)の予防における最近の発展: 包括的レビュー

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=15A0776229&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0776229&from=J-GLOBAL&jstjournalNo=W0107A") }}

著者 (3件)： , ,
資料名：
巻： 26 号： 6 ページ： 1081-1090 発行年： 2015年06月
JST資料番号： W0107A ISSN： 0923-7534 CODEN： ANONE2 資料種別：逐次刊行物 (A)
記事区分：解説発行国：イギリス (GBR) 言語：英語 (EN)

化学療法誘導の吐き気と嘔吐(CINV)の理解の進展により,C...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0776229&from=J-GLOBAL&jstjournalNo=W0107A") }}

消化器作用薬の臨床への応用

, ,

引用文献 (69件)：

Hesketh PJ, Rossi G, Rizzi G et al. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Ann Oncol 2014; 25: 1340-1346.
Aapro M, Rugo H, Rossi G et al. A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy. Ann Oncol 2014; 25: 1328-1333.
Gralla RJ, Bosnjak SM, Hontsa A et al. A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy. Ann Oncol 2014; 25: 1333-1339.
Jahn P, Jordan K, Rizzi G. Improving the functional status of patients with cancer by more effectively preventing chemotherapy-induced nausea and vomiting (CINV): results of a phase 3 study of NEPA (fixed-dose combination of netupitant and palonosetron). Eur J Oncol Nursing 2014; 18: 20-21.
Aapro MS, Gralla R, Karthaus M et al. Multicycle efficacy and safety of NEPA, a fixed-dose antiemetic combination of netupitant and palonosetron, in patients receiving chemotherapy of varying emetogenicity. Ann Oncol 2014; 25(24): iv517-iv541.

, , , , ,

前のページに戻る